المؤلفون: Uryu, Kiyoaki, Imamura, Yoshinori^{Aff2, IDs00280024046664_cor2}, Shimoyama, Rai, Mase, Takahiro, Fujimura, Yoshiaki, Hayashi, Maki, Ohtaki, Megu, Otani, Keiko, Hibino, Makoto, Horiuchi, Shigeto, Fukui, Tomoya, Fukai, Ryuta, Chihara, Yusuke, Iwase, Akihiko, Yamada, Noriko, Tamura, Yukihiro, Harada, Hiromasa, Shinozaki, Nobuaki^{Aff3, Aff16}, Shimada, Toyoshi, Tsuya, Asuka, Fukuoka, Masahiro, Minami, Hironobu^{Aff2, Aff19}

المصدر: Cancer Chemotherapy and Pharmacology. :1-12

المؤلفون: Yu, Zhuchen, Xu, Fei^{Aff1, IDs0022802403620w_cor2}, Zou, Juntao^{Aff1, IDs0022802403620w_cor3}

المصدر: European Journal of Clinical Pharmacology. 80(4):505-517

المؤلفون: Jung-Yueh Chen, Sheng-Kai Liang, Tzu-Yi Chuang, Chia-Yu Chu, Chia-Hung Tu, Yu-Jo Yeh, Yu-Feng Wei, Kuan-Yu Chen

المصدر: Journal of the Formosan Medical Association, Vol 123, Iss 2, Pp 198-207 (2024)

مصطلحات موضوعية: Adverse events, Comorbidity, Epidermal growth factor receptor tyrosine kinase inhibitor, Non-small cell lung cancer, Quality of life, Neutrophil-to-lymphocyte ratio, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S0929664623002917; https://doaj.org/toc/0929-6646

URL الوصول: https://doaj.org/article/35cd2d64adf249559b93739c6530ae0d

المؤلفون: Xiaofei Gu, Yonghong Zhong, Huaqiong Huang

المصدر: Frontiers in Pharmacology, Vol 15 (2024)

مصطلحات موضوعية: epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), rechallenge, osimertinib, non-small cell lung cancer (NSCLC), interstitial lung disease (ILD), Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1410684/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/596cde0bed4f47279799f48de255daa5

المؤلفون: Tian Gan, Jindong Chen, Hao Wang, Conghui Shang, Siqi Xi, Zixu Fan, Ben He, Min Zhang, Liang Zhao

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: non-small cell lung cancer, epidermal growth factor receptor-tyrosine kinase inhibitor, corrected QT interval, risk factor, advanced lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1330165/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/55d2d51f4da2463bbf0ee2f3d05110ed

المؤلفون: Antonia Howaldt, MD, Sandrine Lenglez, BSc, Clara Velmans, MD, Anne Maria Schultheis, MD, Thomas Clahsen, PhD, Mario Matthaei, MD, Jürgen Kohlhase, MD, Christian Vokuhl, MD, Reinhard Büttner, MD, Christian Netzer, MD, Jean-Baptiste Demoulin, PhD, Claus Cursiefen, MD, PhD

المصدر: Ophthalmology Science, Vol 4, Iss 3, Pp 100444- (2024)

مصطلحات موضوعية: Infantile myofibromatosis, PDGFRB, Imatinib, Corneal myofibroma, Receptor tyrosine kinase inhibitor, Ophthalmology, RE1-994

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666914523001768; https://doaj.org/toc/2666-9145

URL الوصول: https://doaj.org/article/0c34c72456184f88bcbbf12bc816fc2d

المؤلفون: Hayashi, Hidetoshi^{Aff1, IDs12325023026169_cor1}, Nishio, Makoto, Takahashi, Michiko, Tsuchiya, Hiroaki, Kasahara-Kiritani, Mami

المصدر: Advances in Therapy. 40(10):4545-4560

المؤلفون: Wanting, Hou, Jian, Zhong, Chaoxin, Xiao, Cheng, Yi, Chengjian, Zhao, Lin, Zhou^{Aff3, IDs00432022045607_cor6}, Dan, Cao^{Aff1, IDs00432022045607_cor7}

المصدر: Journal of Cancer Research and Clinical Oncology. 149(9):5975-5987

المؤلفون: Ya-Tung Liu, Chen-Wei Lin, Chi-Chin Sun, Shih-Chieh Shao, Nan-Ni Chen

المصدر: Taiwan Journal of Ophthalmology, Vol 14, Iss 1, Pp 121-124 (2024)

مصطلحات موضوعية: afatinib, epidermal growth factor receptor-tyrosine kinase inhibitor, keratitis, Ophthalmology, RE1-994

وصف الملف: electronic resource

Relation: http://www.e-tjo.org/article.asp?issn=2211-5056;year=2024;volume=14;issue=1;spage=121;epage=124;aulast=Liu; https://doaj.org/toc/2211-5056; https://doaj.org/toc/2211-5072

URL الوصول: https://doaj.org/article/40f7934395794b0695d91c832981f2d6

المؤلفون: Xue Han, Lan Liang, Chenming He, Qinyou Ren, Jialin Su, Liang Cao, Jin Zheng

المصدر: BMC Complementary Medicine and Therapies, Vol 23, Iss 1, Pp 1-23 (2023)

مصطلحات موضوعية: Lung adenocarcinoma, ZiLongJin Tablet, Epidermal growth factor receptor-tyrosine kinase inhibitor, Real-world study, Network pharmacology, Molecular docking simulation, Other systems of medicine, RZ201-999

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2662-7671

URL الوصول: https://doaj.org/article/3823770dc37a47bf8865d464d9f65823